INGN Key Statistics, Chart & Performance
The current stock price of INGN is 5.555 USD. In the past month the price decreased by -21.61%. In the past year, price decreased by -46.65%.
INGN Technical Analysis
INGN Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to INGN. INGN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
INGN Financial Highlights
Over the last trailing twelve months INGN reported a non-GAAP Earnings per Share(EPS) of -0.94. The EPS increased by 58.22% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -8.27% | ||
| ROE | -12.87% | ||
| Debt/Equity | 0 |
INGN Forecast & Estimates
8 analysts have analysed INGN and the average price target is 13.26 USD. This implies a price increase of 138.7% is expected in the next year compared to the current price of 5.555.
For the next year, analysts expect an EPS growth of 36.25% and a revenue growth 6.81% for INGN
INGN Ownership
INGN Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 19.32 | 192.719B | ||
| ISRG | INTUITIVE SURGICAL INC | 48.15 | 173.049B | ||
| SYK | STRYKER CORP | 23.28 | 137.017B | ||
| BSX | BOSTON SCIENTIFIC CORP | 21.38 | 113.066B | ||
| BDX | BECTON DICKINSON AND CO | 13.51 | 59.944B | ||
| IDXX | IDEXX LABORATORIES INC | 42.85 | 51.472B | ||
| EW | EDWARDS LIFESCIENCES CORP | 25.99 | 45.675B | ||
| RMD | RESMED INC | 22.25 | 39.65B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.83 | 36.738B | ||
| DXCM | DEXCOM INC | 27.65 | 27.29B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About INGN
Company Profile
Inogen, Inc. is a medical technology company, which engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company is headquartered in Goleta, California and currently employs 766 full-time employees. The company went IPO on 2014-02-14. The company supports patient respiratory care by developing, manufacturing, and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One and Inogen Rove systems concentrate the air around the patient to offer a source of supplemental oxygen with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. Its Inogen One and Inogen Rove systems reduce the patient’s reliance on stationary concentrators and scheduled deliveries of tanks with a finite supply of oxygen. Inogen Connect is a wireless connectivity platform for the Inogen One G4, Inogen One G5, Inogen Rove 4, and Inogen Rove 6, consisting of a front-end mobile application for use by long-term oxygen therapy users. The company offers Simeox, which is an airway clearance device.
Company Info
INOGEN INC
859 Ward Drive
Goleta CALIFORNIA 93117 US
CEO: Nabil Shabshab
Employees: 766
Phone: 18055620500
INOGEN INC / INGN FAQ
What does INGN do?
Inogen, Inc. is a medical technology company, which engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company is headquartered in Goleta, California and currently employs 766 full-time employees. The company went IPO on 2014-02-14. The company supports patient respiratory care by developing, manufacturing, and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One and Inogen Rove systems concentrate the air around the patient to offer a source of supplemental oxygen with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. Its Inogen One and Inogen Rove systems reduce the patient’s reliance on stationary concentrators and scheduled deliveries of tanks with a finite supply of oxygen. Inogen Connect is a wireless connectivity platform for the Inogen One G4, Inogen One G5, Inogen Rove 4, and Inogen Rove 6, consisting of a front-end mobile application for use by long-term oxygen therapy users. The company offers Simeox, which is an airway clearance device.
What is the current price of INGN stock?
The current stock price of INGN is 5.555 USD. The price decreased by -1.86% in the last trading session.
Does INOGEN INC pay dividends?
INGN does not pay a dividend.
How is the ChartMill rating for INOGEN INC?
INGN has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
How is the valuation of INOGEN INC (INGN) based on its PE ratio?
INOGEN INC (INGN) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.94).
Can you provide the number of employees for INOGEN INC?
INOGEN INC (INGN) currently has 766 employees.
When does INOGEN INC (INGN) report earnings?
INOGEN INC (INGN) will report earnings on 2026-02-24, after the market close.